American Association of Colleges of Osteopathic Medicine
Non-profit supporting osteopathic medical schools through medical education and research
Based in MD
🤖
AI Overview
With $810K in lobbying spend across 21 quarterly filings, American Association of Colleges of Osteopathic Medicine is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
$810K
Total Spend
5
Years Active
1
Firms Hired
7
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $120K |
| 2023 | $140K |
| 2024 | $250K |
| 2025 | $300K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Issues relating to healthcare and higher education legislation and regulations
- •Issues related to NIH research funding
- •Issues related to NIH research funding and Graduate Medical Education
- •Issues related to NIH research funding and Graduate Medical Education, including Fair Access in Residency (FAIR) Act (H.R. 8850)
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
United Assn of Journeymen & Apprentices of the Plumbing & Pipefitting Industry
$5.7M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Redwood Holdings, LLC FKA Redwood Capital Investments
$2.7M total spend
The United States Pharmacopeial Convention
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.